Tue. Feb 24th, 2026

AstraZeneca gets regulator’s nod to market cancer drug in India

ByBengal Watch Web Desk

Oct 7, 2025

Spread the love

Trastuzumab Deruxtecan is already approved in India for the treatment of metastatic breast cancer and locally advanced or metastatic gastric cancer

Trastuzumab Deruxtecan is already approved in India for the treatment of metastatic breast cancer and locally advanced or metastatic gastric cancer

Post Views: 7

By Bengal Watch Web Desk

Related Post

F-22 Raptor: Why the world’s most advanced stealth fighter stays exclusive to USon February 23, 2026 at 11:16 pm

Feb 23, 2026 Bengal Watch Web Desk

Row over former BJP MP turning away Muslim women from charity event

Feb 23, 2026 Bengal Watch Web Desk

Punjab government announces ‘Meri Rasoi’ scheme; Akali Dal terms it poll gimmick

Feb 23, 2026 Bengal Watch Web Desk

You missed

F-22 Raptor: Why the world’s most advanced stealth fighter stays exclusive to USon February 23, 2026 at 11:16 pm

February 23, 2026 Bengal Watch Web Desk

Row over former BJP MP turning away Muslim women from charity event

February 23, 2026 Bengal Watch Web Desk

Punjab government announces ‘Meri Rasoi’ scheme; Akali Dal terms it poll gimmick

February 23, 2026 Bengal Watch Web Desk

Su-34 revealed: Russia’s fighter jet that can fly from Moscow to Washingtonon February 23, 2026 at 10:48 pm

February 23, 2026 Bengal Watch Web Desk